Here is What to Know Beyond Why Tenet Healthcare Corporation (THC) is a Trending Stock
Tenet (THC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
THC - Tenet Healthcare Corporation
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$240.36
DETAILS
HIGH:
$260.00
LOW:
$224.00
MEDIAN:
$240.00
CONSENSUS:
$240.36
UPSIDE:
22.17%
Stock News
Tenet Healthcare (THC) Registers a Bigger Fall Than the Market: Important Facts to Note
Tenet Healthcare (THC) reached $195.19 at the closing of the latest trading day, reflecting a -2.01% change compared to its last close.
Rep. Jonathan L. Jackson Sells Robinhood Markets, Inc. (NASDAQ:HOOD) Stock
Representative Jonathan L. Jackson (D-Illinois) recently sold shares of Robinhood Markets, Inc. (NASDAQ: HOOD). In a filing disclosed on January 08th, the Representative disclosed that they had...
Tenet Healthcare (NYSE:THC) Stock Acquired Rep. Jonathan L. Jackson
Representative Jonathan L. Jackson (D-Illinois) recently bought shares of Tenet Healthcare Corporation (NYSE: THC). In a filing disclosed on January 08th, the Representative disclosed that they...
Rep. Jonathan L. Jackson Purchases Shares of Palantir Technologies Inc. (NASDAQ:PLTR)
Representative Jonathan L. Jackson (D-Illinois) recently bought shares of Palantir Technologies Inc. (NASDAQ: PLTR). In a filing disclosed on January 08th, the Representative disclosed that they...
Shopify (NASDAQ:SHOP) Stock Acquired Rep. Jonathan L. Jackson
Representative Jonathan L. Jackson (D-Illinois) recently bought shares of Shopify Inc. (NASDAQ: SHOP). In a filing disclosed on January 08th, the Representative disclosed that they had bought...
Rep. Jonathan L. Jackson Sells Off Shares of Netflix, Inc. (NASDAQ:NFLX)
Representative Jonathan L. Jackson (D-Illinois) recently sold shares of Netflix, Inc. (NASDAQ: NFLX). In a filing disclosed on January 08th, the Representative disclosed that they had sold between...
Rep. Jonathan L. Jackson Sells Off Shares of MercadoLibre, Inc. (NASDAQ:MELI)
Representative Jonathan L. Jackson (D-Illinois) recently sold shares of MercadoLibre, Inc. (NASDAQ: MELI). In a filing disclosed on January 08th, the Representative disclosed that they had sold...
Hospital Industry Reshaping Under Strain: 3 Stocks Worth Watching
THC, UHS and CYH are showing strength through outpatient focus and efficiency-improving efforts, despite hospital industry headwinds.
Here's Why Tenet Healthcare (THC) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Tenet to Report its Fourth Quarter 2025 Results on February 11th
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) will release its fourth quarter 2025 results before the market opens on Wednesday, February 11, 2026, to be followed by a...
Why Tenet Healthcare (THC) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Tenet Healthcare Corporation (NYSE:THC) Receives Consensus Recommendation of “Moderate Buy” from Analysts
Tenet Healthcare Corporation (NYSE: THC - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the twenty-one analysts that are presently covering the stock,...
Why Tenet Healthcare (THC) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Is Trending Stock Tenet Healthcare Corporation (THC) a Buy Now?
Tenet (THC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Tenet (THC) Is Considered a Good Investment by Brokers: Is That True?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)...
3,395 Shares in Tenet Healthcare Corporation $THC Acquired by B. Riley Wealth Advisors Inc.
B. Riley Wealth Advisors Inc. purchased a new stake in Tenet Healthcare Corporation (NYSE: THC) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange...
Elizabeth Warren Slams GOP For Leaving Families 'In the Dirt,' Warns Of Higher Costs As 'Last Chance' To Save ACA Subsidies Fails
Elizabeth Warren slams GOP for blocking ACA subsidies, warning of spiking healthcare costs and leaving American families "in the dirt."
Here's Why Tenet Healthcare (THC) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Cerity Partners LLC Boosts Stock Position in Tenet Healthcare Corporation $THC
Cerity Partners LLC grew its position in shares of Tenet Healthcare Corporation (NYSE: THC) by 10.4% during the undefined quarter, according to its most recent filing with the Securities and...
Price Targets
Tenet Healthcare price target lowered to $229 from $252 at Wells Fargo
$229.00
(was $208.24)
Wells Fargo
Tenet Healthcare price target raised to $247 from $232 at Morgan Stanley
$247.00
(was $195.02)
Craig Hettenbach
·
Morgan Stanley
Tenet Healthcare price target raised to $257 from $238 at Guggenheim
$257.00
(was $215.13)
Guggenheim
Tenet Healthcare price target raised to $240 from $229 at Barclays
$240.00
(was $186.68)
Andrew Mok
·
Barclays
Tenet Healthcare price target raised to $240 from $225 at Truist
$240.00
(was $200.74)
Truist Financial
Tenet Healthcare price target raised to $252 from $230 at RBC Capital
$252.00
(was $212.48)
RBC Capital
Tenet Healthcare (THC) PT Raised to $245 at Cantor Fitzgerald
$245.00
(was $208.72)
Sarah James
·
Raymond James
Tenet Healthcare price target raised to $260 from $238 at UBS
$260.00
(was $208.72)
UBS
Tenet Healthcare price target raised to $232 from $225 at Morgan Stanley
$232.00
(was $207.78)
Morgan Stanley
Tenet Healthcare price target raised to $238 from $221 at Guggenheim
$238.00
(was $204.62)
Guggenheim
Tenet Healthcare price target raised to $225 from $194 at Mizuho
$225.00
(was $199.13)
Ann Hynes
·
Mizuho Securities
Tenet Healthcare price target raised to $225 from $205 at Truist
$225.00
(was $192.65)
David MacDonald
·
Truist Financial
Tenet Healthcare assumed with a Buy at Goldman Sachs
$224.00
(was $190.00)
Scott Fidel
·
Goldman Sachs
Tenet Healthcare price target raised to $225 from $205 at KeyBanc
$225.00
(was $204.83)
Matthew Gillmor
·
KeyBanc
Tenet Healthcare price target raised to $238 from $200 at Wells Fargo
$238.00
(was $199.76)
Stephen Baxter
·
Wells Fargo
Tenet Healthcare price target raised to $229 from $208 at Barclays
$229.00
(was $186.12)
Barclays
Tenet Healthcare price target raised to $205 from $190 at Truist
$205.00
(was $172.27)
David MacDonald
·
Truist Financial
Tenet Healthcare initiated with an Overweight at Morgan Stanley
$165.00
(was $133.04)
Morgan Stanley
Tenet Healthcare price target lowered to $185 from $200 at KeyBanc
$185.00
(was $128.80)
Matthew Gillmor
·
KeyBanc
Tenet Healthcare downgraded to Neutral from Buy at Goldman Sachs
$140.00
(was $139.10)
Jamie Perse
·
Goldman Sachs